CCRL2 and acute myeloid leukemia: Furthermore, CCRL2 has been implicated in activating cell-intrinsic IFN-γ/STAT1 signaling in TP53-mutant AML, via JAK2-dependent and independent pathways, even in the absence of exogenous IFN-γ [28] (Figure 6G).